AeroVironment Inc.

step: 01 title: Business Model & Value Chain ticker: AVAV source: coverage-next-full date: 2026-05-28

AVAV — Step 01: Business Model & Value Chain

TL;DR

AeroVironment is a defense technology company that designs, develops, manufactures, and supports autonomous systems, precision strike weapons (loitering munitions), counter-UAS, space-based platforms, directed energy systems, and cyber/electronic warfare capabilities — primarily for the U.S. Department of Defense, U.S. government agencies, and allied/foreign militaries. With the BlueHalo acquisition closed 5/1/25, AVAV operates two reportable segments — Autonomous Systems (AxS) and Space, Cyber and Directed Energy (SCDE) — and now spans air, land, sea, space, and cyber domains [S1]. Revenue model is hardware-led contract sales (cost-plus, fixed-price, and time-and-materials structures) bundled with software platforms (Kinesis C2, AV_Halo AI suite, HaloCortex OSINT) and recurring service revenue (training, spares, integration). The model is highly leveraged to U.S. and allied defense procurement budgets — 75% of FY25 revenue was U.S. government or foreign military sales [S2].

1. What the Company Does

One-sentence description

AeroVironment builds and sells combat-relevant defense technology — small/medium uncrewed aircraft systems, loitering munitions, counter-drone systems, space communications, directed-energy weapons, and cyber/EW capabilities — primarily to the U.S. DoD and allied governments [S1].

Product line map (post-BlueHalo, FY26+)

Segment 1 — Autonomous Systems (AxS) — combines legacy UxS + LMS + MacCready Works + BlueHalo's C-UAS/EW

Segment 2 — Space, Cyber and Directed Energy (SCDE) — all from BlueHalo

2. Value Chain Position

            UPSTREAM                              AVAV                              DOWNSTREAM
┌─────────────────────┐         ┌────────────────────────────────┐         ┌─────────────────────────┐
│  Component vendors  │  →  →   │  R&D / Engineering             │  →  →   │  U.S. DoD (35%)         │
│  (batteries, IC,    │         │  Manufacturing (national       │         │  U.S. Army (20%)        │
│   composites,       │         │   footprint, primarily leased) │         │  Other US gov (27%)     │
│   sensors, motors)  │         │  Test & integration            │         │  FMS / Foreign (53%)    │
│                     │         │  Sales (direct + prime sub)    │         │   - Ukraine 18%         │
│  Sub-contractors    │         │  Service / training / spares   │         │   - NATO allies         │
│  (key sub-systems)  │         │                                │         │   - Indo-Pacific        │
└─────────────────────┘         └────────────────────────────────┘         └─────────────────────────┘
                                          ↑                                            ↑
                                          │                                            │
                            ┌─────────────┴──────────────┐                ┌────────────┴─────────────┐
                            │  Software / AI platforms   │                │  Strategic Advisory      │
                            │  (Kinesis, AV_Halo,        │                │  Group (retired Gen/Flag │
                            │   HaloCortex)              │                │   officers)              │
                            └────────────────────────────┘                └──────────────────────────┘

AVAV's value-chain position: integrator at the top of the unmanned/autonomous systems stack — owns the platform, the autonomy software, the supply-chain orchestration, and the customer relationship. Component-level commoditization risk is offset by mission-critical software/integration moat.

3. Revenue Model

Revenue Types (per 10-K disclosures and earnings releases [S2][S3])

1. Product revenue — sale of UAS, LMS, C-UAS systems, antennas, etc. Pre-BlueHalo: ~70% of FY25 revenue.
2. Service revenue — training, spares, integration, sustainment, cyber services, OSINT analytics. Pre-BlueHalo: ~30% of FY25 revenue. Post-BlueHalo: higher mix from cyber/mission systems consulting work. Q3 FY26: services = $130.2M / 32% of revenue.

Contract Types

• Fixed-price — most product sales (Switchblade, Puma per-unit)
• Cost-plus-fixed-fee (CPFF) — R&D and engineering development
• Time-and-materials (T&M) — cyber and mission systems engagements
• IDIQ / Other Transaction Agreements (OTAs) — frequently used for Switchblade pull-down orders; the BADGER SCAR program (stop-worked in Q1 2026) was an OTA [S3]

Sales Channels

• Direct to U.S. DoD via prime contracts or as prime
• Sub-contracted under primes (Lockheed, RTX, Northrop) for selected programs
• Foreign Military Sales (FMS) — U.S. State Dept / DSCA-authorized sales to allies
• Direct Commercial Sales (DCS) — direct to allied governments
• Commercial — small share; critical-infrastructure protection, OSINT, R&D

4. Unit Economics (best-available estimates — judgment, not disclosed)

[Judgment based on defense industry analyst estimates; specific unit economics not in public filings.]

5. Customer Concentration (FY25 pre-BlueHalo, per 10-K) [S2]

• U.S. Army: ~20% of revenue
• Other U.S. government agencies + government subcontractors: ~27% of revenue
• Foreign customers (incl. FMS): ~53% of revenue, of which Ukraine alone = 18% of total revenue
• Total U.S. government (DoD direct + indirect): ~75% of revenue
• DoD direct: ~35% of revenue
• Post-BlueHalo expectation: U.S. DoD/U.S. government proportion increases in FY26 [S2]

This is highly concentrated. Material risk from any one of: U.S. Army budget cuts, DoD reprioritization (DOGE review), Ukraine aid wind-down.

6. Why It Wins (preliminary view — refined in Step 10)

1. Combat-proven products — Switchblade with 100k+ Ukraine combat deployments; competitors are unproven at scale [S4]
2. NDAA / Blue UAS certification — U.S. fenced market excludes Chinese DJI/Autel [S4]
3. Program of Record (PoR) entrenchment — Switchblade, Puma 3 AE, JUMP 20 are funded multi-year programs
4. Strategic Advisory Group political moat — retired General/Flag officers provide DoD relationship infrastructure [S2]
5. Patent + IP portfolio — ~503 issued U.S. patents post-BlueHalo [S2]

7. Why It Could Lose (preliminary view — refined in Step 10)

1. Anduril competitive escalation — best-funded private rival, software-native, building competing LMS + C-UAS portfolio [S4]
2. Skydio share threat in SUAS — Pentagon-favored, autonomy-leading [S4]
3. DOGE budget review — could deprioritize AVAV programs (BADGER SCAR stop-work in Q1 2026 = early evidence) [S3]
4. BlueHalo integration risk — material weakness remediation, cultural fit, talent retention [S2]
5. U.S. government IP licensing — government can use/license AVAV IP developed under contract, limiting moat from gov-funded R&D [S2]

8. Thesis Tracker Update

• Confirmed dual-segment structure under AxS / SCDE
• Confirmed 75% U.S. government revenue dependence
• Switchblade is the strategic asset; BlueHalo materially expands C-UAS / Space / Cyber TAM
• Confidence: still MEDIUM-LOW given recent execution issues; will firm up after Steps 04, 09, 10

Source Index

• [S1] AVAV 10-K FY25 — Item 1. Business, accession 0001558370-25-008838
• [S2] AVAV 10-K FY25 — Item 1. Customers, Item 1A. Risk Factors
• [S3] AVAV Q3 FY26 8-K + press release (2026-03-10), accession 0001104659-26-025841
• [S4] AVAV_financials/industry/competitive_landscape.md (synthesis from Tavily web research)

step: 04 title: Financial Quality (incl. Adversarial Sweep) ticker: AVAV source: coverage-next-full date: 2026-05-28

AVAV — Step 04: Financial Quality & Adversarial Sweep

TL;DR

Financial quality is MIXED — leaning cautious through FY26. Positives: revenue growth structurally accelerating (+14.5% FY25 standalone → +130% FY26 inorganic via BlueHalo), $1.1B record funded backlog (+52% YoY) [S3], non-GAAP EBITDA tracking guidance. Concerns: (1) Three goodwill impairments in 4 years (FY23 Tomahawk/Telerob $-180M; FY26 Q3 BADGER Space $-151M), (2) BlueHalo had pre-acquisition material weaknesses in internal controls — acquirer explicitly disclosed this in 10-K [S1], (3) operating cash flow $(1.3)M FY25 and $(124)M Q1 FY26 reflects working-capital absorption from Switchblade ramp + integration, (4) Q3 FY26 revenue miss vs. consensus and FY26 guidance cut, (5) ~$175M annual intangible amortization will suppress GAAP profitability through FY28+. Adversarial sweep result: No active short reports, no SEC investigation, no material litigation disclosed beyond ordinary defense-contractor cases. The class-action securities/employment suit filed 2021-08 is the only flagged item. Net: financial quality is real but obscured by acquisition accounting; investors must judge on non-GAAP through FY27.

1. Statement-Quality Adjustments

GAAP-to-Economic earnings bridge (annualized FY26 mid)

Implication: Don't take GAAP at face value through FY27. Non-GAAP EBITDA + adjusted cash earnings are the meaningful read.

Quality red flags vs. quality positives

2. Adversarial Research Sweep

Short reports / investigations / lawsuits

Specific adversarial angles worth pre-empting

1. "3 goodwill impairments in 4 years means M&A discipline is poor" — fair concern. BUT: Arcturus (FY21) has produced JUMP 20 with strong PoR economics, so not all M&A has failed. Tomahawk and BADGER (BlueHalo space program) are the specific failures. Watch BlueHalo cyber/EW for similar risk. [Judgment]

2. "BlueHalo material weakness = AVAV is bringing in a not-public-ready entity" — explicit 10-K disclosure makes this a known risk, not a surprise. Remediation timeline typically 18-24 months. The audit firm-of-record (EY) accepted the merger without qualification, so the remediation plan is presumably credible. [Judgment]

3. "Q3 FY26 miss + guidance cut suggests organic deceleration is being masked by BlueHalo" — partially true. Organic Q3 FY26 ~$232M vs. $167.6M PY = +38% organic, so the legacy AV business is not decelerating. But BlueHalo's Q3 contribution ($176M) was below the implied Q1-Q2 run-rate, suggesting BlueHalo ramp choppier than projected. [Judgment, S3]

4. "Arlington Capital's 39.5% block = secondary supply overhang" — real. Lock-up typically 6-12 months; Arlington will sell over 12-24 months as PE fund-of-funds distribution. Stock-price headwind structural for that period. [Judgment, A16]

5. "BADGER SCAR stop-work is a leading indicator for other BlueHalo program cuts" — bear concern, hard to disprove. Watch FY27 Q1-Q2 disclosures for incremental Space program awards or cuts. [Judgment]

Forensic checks

• Days Sales Outstanding (DSO): ~110 days (Receivables $250M / Daily revenue $2.25M FY25). Defense industry norm given gov payment cycles. No anomaly [S6, Calculation]
• Inventory days: Materially elevated FY24-Q1 FY26 — Switchblade production-ahead-of-demand pattern. Watch for write-down risk if demand softens [S6]
• Goodwill to equity: Materially elevated post-BlueHalo (~$2-3B goodwill / book equity to be confirmed in FY26 10-K). High impairment-test sensitivity [Estimate]
• R&D expensing vs. capitalization: R&D appears properly expensed; no aggressive capitalization detected [S1]
• Customer-funded R&D as revenue: Disclosed separately in segment reporting; no commingling apparent [S1]

3. Financial Quality Score (1-5 scale)

4. Implications for Thesis

• Use non-GAAP EBITDA + adjusted economic earnings for valuation through FY27 — GAAP will mislead. [Step 14 / /complete-coverage]
• Apply impairment-risk discount to AVAV's terminal valuation given track record (3 impairments in 4 years). [Step 14]
• Bear case must explicitly stress test additional BlueHalo program cuts — BADGER may not be the last. [Step 15]
• Working capital build is real but acceptable given backlog growth supports demand. Watch for inventory write-down if Switchblade demand softens (unlikely near-term).
• Material weakness remediation timeline (18-24 months) is a watch-item but not a thesis-breaker — disclosed and being managed.

5. Tables — Multi-year Financial Snapshot

Annual Income Statement Highlights ($M)

G=GAAP, N=Non-GAAP. [Source: S1, S3, S6]

Annual Cash Flow ($M)

[S6][S1]

6. Open Questions

1. FY26 10-K goodwill/intangible balance — what is true post-BlueHalo carrying value?
2. BlueHalo segment-level profitability — has it been disclosed in Q1-Q3 FY26 10-Qs? (currently aggregate only)
3. Working-capital normalization trajectory — when does OCF turn positive?
4. Material weakness remediation status — first disclosure in FY26 10-K (June 2026)
5. Any additional Space programs at SCAR stop-work risk?

Source Index